Clinical ResearchRelationship of Dapagliflozin With Serum Sodium: Findings From the DAPA-HF Trial
Under a Creative Commons license
open access
Central Illustration
Key Words
dapagliflozin
heart failure
hyponatremia
sodium
sodium glucose cotransporter 2 inhibitor
Abbreviations and Acronyms
eGFR
estimated glomerular filtration rate
HF
heart failure
HFrEF
heart failure and reduced ejection fraction
KCCQ-TSS
Kansas City Cardiomyopathy Questionnaire-total symptom score
LVEF
left ventricular ejection fraction
NT-proBNP
N-terminal pro–B-type natriuretic peptide
SBP
systolic blood pressure
SGLT2
sodium-glucose cotransporter 2
Cited by (0)
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.